RHYTHM PHARMACEUTICALS INC
RYTM·76243J105·US·Common Stock·Healthcare - Biotechnology-13D/G
RYTM (RHYTHM PHARMACEUTICALS INC) is held by 164 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($740.2M), BlackRock, Inc. ($683.6M), BAKER BROS. ADVISORS LP ($622.3M). Net institutional sentiment: Mixed.
164
Holders
(9 Elite)
$7.4B
Total Value
54% (169)
Consensus
91 buying - 78 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 15, 2026 · Insiders Sep 14, 2026 · Activists Oct 13, 2026 · Congress none
InsiderMPMeeker David PSell $3.1MSep 14, 2026
InsiderMPMeeker David PSell $900KSep 14, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 178
1 / 9
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer